{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T12:02:09Z","timestamp":1726920129755},"reference-count":61,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,2,15]]},"DOI":"10.18632\/aging.203895","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T21:03:20Z","timestamp":1644872600000},"page":"1529-1548","source":"Crossref","is-referenced-by-count":4,"title":["Construction and validation of a prognostic risk model of angiogenesis factors in skin cutaneous melanoma"],"prefix":"10.18632","volume":"14","author":[{"given":"Songyun","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Burn and Plastic Surgery, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Oncology Department, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengchuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Office of Medical Ethics, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Burn and Plastic Surgery, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and Risk Factors of Melanoma.","volume":"10","author":"Wernberg","year":"2020","journal-title":"Surg Clin North Am"},{"key":"2","doi-asserted-by":"publisher","first-page":"djv381","DOI":"10.1093\/jnci\/djv381","article-title":"Stemming the Rising Incidence of Melanoma: Calling Prevention to Action.","volume":"10","author":"Guy","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"4","first-page":"1005","article-title":"Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification.","volume":"2","author":"Alaibac","year":"2014","journal-title":"In Vivo"},{"key":"5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00709-016-1038-z","article-title":"Intercellular crosstalk in human malignant melanoma.","volume":"25","author":"Smetana","year":"2017","journal-title":"Protoplasma"},{"key":"6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13402-020-00501-z","article-title":"CXCL-10: a new candidate for melanoma therapy?","volume":"4","author":"Mirzaei","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"7","first-page":"126","article-title":"[Cutaneous melanoma].","volume":"14","author":"Ocampo-Candiani","year":"2010","journal-title":"Gac Med Mex"},{"key":"8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","article-title":"Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.","volume":"2","author":"Adjei","year":"2015","journal-title":"Oncologist"},{"key":"9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semcancer.2019.06.015","article-title":"Role of angiogenesis in melanoma progression: Update on key angiogenic mechanisms and other associated components.","volume":"5","author":"Aung","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1186\/s12885-019-6474-7","article-title":"Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer.","volume":"1","author":"He","year":"2019","journal-title":"BMC Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10456-018-9645-2","article-title":"Angiogenesis in pancreatic cancer: current research status and clinical implications.","volume":"2","author":"Liu","year":"2019","journal-title":"Angiogenesis"},{"key":"12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets.","volume":"2","author":"Larriv\u00e9e","year":"2017","journal-title":"Angiogenesis"},{"key":"13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/jclinpath-2015-203482","article-title":"Angiogenesis in melanoma: an update with a focus on current targeted therapies.","volume":"6","author":"Aung","year":"2016","journal-title":"J Clin Pathol"},{"key":"14","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.18632\/oncotarget.3655","article-title":"Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.","volume":"6","author":"Jirstr\u00f6m","year":"2015","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Stemke-Hale","year":"2013","journal-title":"Nat Commun"},{"key":"16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13046-018-0763-x","article-title":"Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma.","volume":"3","author":"Rofstad","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"1073274818789361","DOI":"10.1177\/1073274818789361","article-title":"Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers.","volume":"2","author":"Iwase","year":"2018","journal-title":"Cancer Control"},{"key":"18","doi-asserted-by":"publisher","first-page":"eaak9670","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.","volume":"9","author":"De Palma","year":"2017","journal-title":"Sci Transl Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/SLA.0b013e31822a72dc","article-title":"Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin.","volume":"25","author":"Velazquez","year":"2011","journal-title":"Ann Surg"},{"key":"20","doi-asserted-by":"publisher","first-page":"20493","DOI":"10.1038\/s41598-020-77568-z","article-title":"Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.","volume":"1","author":"Jin","year":"2020","journal-title":"Sci Rep"},{"key":"21","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.3889\/oamjms.2019.782","article-title":"Beta Blockers and Melanoma.","volume":"7","author":"Lotti","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.hoc.2009.03.007","article-title":"Tumor angiogenesis in melanoma.","volume":"2","author":"Marneros","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"23","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1158\/1541-7786.MCR-18-1372","article-title":"AKT1Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.","volume":"1","author":"Davies","year":"2019","journal-title":"Mol Cancer Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.14196\/mjiri.32.135","article-title":"Correlation between important genes of mTOR pathway (and) in Iranian women with sporadic breast cancer.","volume":"3","author":"Keyhani","year":"2018","journal-title":"Med J Islam Repub Iran"},{"key":"25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/PPO.0b013e31824d448c","article-title":"The role of the PI3K-AKT pathway in melanoma.","volume":"1","author":"Davies","year":"2012","journal-title":"Cancer J"},{"key":"26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fcell.2019.00304","article-title":"Thymosin \u03b24 Regulates Focal Adhesion Formation in Human Melanoma Cells and Affects Their Migration and Invasion.","volume":"7","author":"Mazur","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis.","volume":"27","author":"Welsh","year":"2013","journal-title":"J Intern Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR Pathway in Angiogenesis.","volume":"4","author":"Maity","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamadermatol.2020.0470","article-title":"Evaluation of Sex-Specific Incidence of Melanoma.","volume":"15","author":"Whiteman","year":"2020","journal-title":"JAMA Dermatol"},{"key":"30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/ije\/dyaa009","article-title":"Body mass index and height and risk of cutaneous melanoma: Mendelian randomization analyses.","volume":"4","author":"Whiteman","year":"2020","journal-title":"Int J Epidemiol"},{"key":"31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.","volume":"1","author":"Kaper","year":"2018","journal-title":"Lancet Oncol"},{"key":"32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10585-007-9093-7","article-title":"Serum angiogenin levels predict treatment response in patients with stage IV melanoma.","volume":"2","author":"Pyrh\u00f6nen","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"33","doi-asserted-by":"publisher","first-page":"185687","DOI":"10.1155\/2010\/185687","article-title":"Angiogenesis and progression in human melanoma.","volume":"201","author":"Vacca","year":"2010","journal-title":"Dermatol Res Pract"},{"key":"34","doi-asserted-by":"publisher","first-page":"e0210399","DOI":"10.1371\/journal.pone.0210399","article-title":"Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.","volume":"1","author":"Akslen","year":"2019","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"publisher","first-page":"7876","DOI":"10.3390\/ijms16047876","article-title":"The changes of angiogenesis and immune cell infiltration in the intra- and peri-tumoral melanoma microenvironment.","volume":"1","author":"Dvorackova","year":"2015","journal-title":"Int J Mol Sci"},{"key":"36","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.ctrv.2020.102084","article-title":"Impact of high tumor mutational burden in solid tumors and challenges for biomarker application.","volume":"8","author":"Amir","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"37","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1634\/theoncologist.2019-0244","article-title":"Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.","volume":"2","author":"Reddy","year":"2020","journal-title":"Oncologist"},{"key":"38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/labinvest.2016.143","article-title":"Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.","volume":"9","author":"Wilmott","year":"2017","journal-title":"Lab Invest"},{"key":"39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/php.12640","article-title":"Hormonal Regulation of the Repair of UV Photoproducts in Melanocytes by the Melanocortin Signaling Axis.","volume":"9","author":"D'Orazio","year":"2017","journal-title":"Photochem Photobiol"},{"key":"40","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The Genetic Evolution of Melanoma from Precursor Lesions.","volume":"37","author":"Bastian","year":"2015","journal-title":"N Engl J Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.","volume":"3","author":"Kurzrock","year":"2021","journal-title":"Cancer Cell"},{"key":"42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41588-020-00752-4","article-title":"The association between tumor mutational burden and prognosis is dependent on treatment context.","volume":"5","author":"Long Roche","year":"2021","journal-title":"Nat Genet"},{"key":"43","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/1878-0261.12748","article-title":"Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.","volume":"1","author":"Kurzrock","year":"2020","journal-title":"Mol Oncol"},{"key":"44","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.","volume":"1","author":"Choi","year":"2019","journal-title":"Nat Commun"},{"key":"45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1158\/1078-0432.CCR-19-2309","article-title":"Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma.","volume":"2","author":"Jagannath","year":"2020","journal-title":"Clin Cancer Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/14728214.2017.1336537","article-title":"Emerging growth factor receptor antagonists for the treatment of advanced melanoma.","volume":"2","author":"Chandra","year":"2017","journal-title":"Expert Opin Emerg Drugs"},{"key":"47","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.","volume":"17","author":"Gajewski","year":"2017","journal-title":"Cell"},{"key":"48","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/em.21859","article-title":"Mechanisms of chromosomal instability in melanoma.","volume":"5","author":"Thomas","year":"2014","journal-title":"Environ Mol Mutagen"},{"key":"49","doi-asserted-by":"publisher","first-page":"e18369","DOI":"10.1371\/journal.pone.0018369","article-title":"Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.","volume":"6","author":"Simpson","year":"2011","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/diagnostics11071238","article-title":"Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma.","volume":"1","author":"Wagner","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fphys.2013.00159","article-title":"Macrophages and chemokines as mediators of angiogenesis.","volume":"4","author":"Mohamadzadeh","year":"2013","journal-title":"Front Physiol"},{"key":"52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13073-019-0647-5","article-title":"Prognostic value of B cells in cutaneous melanoma.","volume":"1","author":"Vincent","year":"2019","journal-title":"Genome Med"},{"key":"53","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1038\/s41467-019-12160-2","article-title":"B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.","volume":"1","author":"Glatz","year":"2019","journal-title":"Nat Commun"},{"key":"54","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fonc.2020.00424","article-title":"BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining.","volume":"1","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"55","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.18632\/aging.103054","article-title":"A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment.","volume":"1","author":"Liao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"56","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: cancer biology and therapeutics.","volume":"3","author":"Nakagama","year":"2014","journal-title":"Med Res Rev"},{"key":"57","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/jid.2009.97","article-title":"FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies.","volume":"12","author":"Katoh","year":"2009","journal-title":"J Invest Dermatol"},{"key":"58","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1109\/EMBC.2018.8512542","article-title":"Identification of Primary and Metastatic Melanoma based on Copy Number Variation.","volume":"201","author":"Cho","year":"2018","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"59","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pathol.2015.12.002","article-title":"Melanoma progression.","volume":"4","author":"Elder","year":"2016","journal-title":"Pathology"},{"key":"60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.29252\/rbmb.9.1.40","article-title":"The Relationship betweenCopy Number Variation, Protein Expression, and Angiogenesis in Sporadic Breast Cancer.","volume":"9","author":"Keyhani","year":"2020","journal-title":"Rep Biochem Mol Biol"},{"key":"61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fcell.2020.00557","article-title":"Comprehensive Analysis of Differentially Expressed lncRNAs in Gastric Cancer.","volume":"8","author":"Juan","year":"2020","journal-title":"Front Cell Dev Biol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:37:37Z","timestamp":1645461457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2,15]]}},"alternative-id":["203895","35157610"],"URL":"https:\/\/doi.org\/10.18632\/aging.203895","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}